Enhanze SC FDA Approval Status
FDA Approved: No
Brand name: Enhanze SC
Generic name: recombinant human hyaluronidase
Company: Halozyme Therapeutics, Inc.
Treatment for: Drug Delivery
Enhanze SC is a local formulation of recombinant human hyaluronidase intended for use as a "spreading agent" to enhance the drug delivery of local anesthesia, contrast agents, and for subcutaneous fluid replacement (also called hypodermoclysis).
Development timeline for Enhanze SC
| Date | Article |
|---|---|
| Mar 28, 2005 | Halozyme Therapeutics Files NDA for Enhanze SC |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
